EssilorLuxottica Société anonyme (ESLOY)
OTCMKTS
· Delayed Price · Currency is USD
141.75
+1.55 (1.11%)
Jun 6, 2025, 3:59 PM EDT
ESLOY Revenue
In the year 2024, EssilorLuxottica Société anonyme had annual revenue of 26.51B EUR with 4.38% growth. EssilorLuxottica Société anonyme had revenue of 13.22B in the half year ending December 31, 2024, with 5.74% growth.
Revenue
26.51B EUR
Revenue Growth
+4.38%
P/S Ratio
4.75
Revenue / Employee
172.69K EUR
Employees
153,498
Market Cap
130.46B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.51B | 1.11B | 4.38% |
| Dec 31, 2023 | 25.40B | 901.00M | 3.68% |
| Dec 31, 2022 | 24.49B | 4.67B | 23.58% |
| Dec 31, 2021 | 19.82B | 5.39B | 37.36% |
| Dec 31, 2020 | 14.43B | -2.96B | -17.03% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
EssilorLuxottica Société anonyme News
- 2 days ago - EssilorLuxottica signs an agreement to acquire A-Look, Seen and OWL retail stores in Malaysia - GlobeNewsWire
- 3 days ago - How Ray-Ban maker EssilorLuxottica’s all-pervasive €112 billion empire has disrupted and dominated how we see the world - Fortune
- 3 days ago - EssilorLuxottica: successful Euro 1 billion bond issuance - GlobeNewsWire
- 3 days ago - EssilorLuxottica: Result of the payment of dividends in shares and record of the corresponding capital increase - GlobeNewsWire
- 7 days ago - EssilorLuxottica to acquire Optegra in med-tech expansion - Seeking Alpha
- 7 days ago - Essilorluxottica to buy Optegra eyecare clinics - Reuters
- 8 days ago - Ray-Ban Maker EssilorLuxottica to Buy Optegra in Medical AI Push - WSJ
- 8 days ago - EssilorLuxottica to acquire Optegra clinics, another leap forward in its med-tech strategy - GlobeNewsWire